Table 3 Extent of variation(s) in biochemical and enzymatic parameters in different groups treated with CCl4 or silymarin or LFE. The data represents mean ± SD of six independent observations
Parameters (Units) | Control | CCl4 | Silymarin | LFE (Low Dose) | LFE (High Dose) |
|---|---|---|---|---|---|
ALP (K.A.) | 7.75 ± 0.17 | 28.52 ± 1.87 ** | 10.50 ± 1.61 NS | 18.48 ± 1.33 ** | 12.99 ± 0.22 ** |
ACP (K.A.) | 4.06 ± 0.48 | 7.35 ± 0.11 ** | 16.55 ± 0.43 ** | 14.35 ± 0.34 *** | 10.79 ± 0.50 ** |
AST (u/ml) | 61.78 ± 2.48 | 133.21 ± 3.94*** | 75.26 ± 3.29 *** | 126.27 ± 2.73 *** | 86.12 ± 4.29 *** |
ALT (u/ml) | 51.27 ± 1.58 | 138.29 ± 4.83 *** | 68.28 ± 3.97 *** | 109.93 ± 3.75 *** | 81.28 ± 4.17 *** |
Protein (g/dl) | 7.61 ± 0.27 | 4.42 ± 0.30 * | 7.40 ± 0.30 NS | 4.74 ± 0.10 ** | 5.50 ± 0.19 * |